[Pubmed] SEC-based isolation of phosphatidylserine-liposomes from biological samples for preclinical studies
-
RSS-Bot
Auteur du sujet - Ami(e) de Diamant

- Messages : 5687
- Enregistré le : 31 mai 2020 09:57
- 5
- Zodiaque :
- Âge : 22
- Contact :
[Pubmed] SEC-based isolation of phosphatidylserine-liposomes from biological samples for preclinical studies
Anal Bioanal Chem. 2026 Mar 16. doi: 10.1007/s00216-026-06436-y. Online ahead of print.
ABSTRACT
Autoimmune diseases represent a significant clinical challenge due to their high prevalence, chronic progression, and profound impact on patients' quality of life. Despite advances in understanding their pathophysiological mechanisms, in most cases, only palliative treatments are available. In this regard, a novel therapeutic approach is under development, using phosphatidylserine-liposomes (PS-Liposomes) encapsulating specific antigenic peptides that trigger the autoimmune attack. By varying the encapsulated antigen, this method offers the potential to treat different autoimmune diseases. The development of robust bioanalytical methods to characterize PS-Liposomes in biological fluids is of great importance to evaluate their efficacy and safety in preclinical trials. This presents a significant challenge due to the presence of extracellular vesicles and proteins in blood with similar size and composition to PS-Liposomes. In this study, size exclusion chromatography (SEC) was assessed for the isolation of PS-Liposomes encapsulating acetylcholine receptor peptide (AChR), intended for myasthenia gravis treatment, from minipig serum samples. A home-packed column filled with Sepharose 2B-CL resin and two commercial columns with agarose resin (qEV 35 nm and qEV 70 nm) were tested by using fluorescently labelled PS-Liposomes. Fractions containing PS-Liposomes were monitored by flow cytometry and qEV columns were selected for further experiments. For PS-liposome preconcentration of the obtained fractions, two different methodologies were also evaluated (Centrisart filters and qEV kit). Lipid and antigenic peptide recoveries obtained for each method were determined by HPLC-ELSD and HPLC-MS, and the optimum isolation and preconcentration approach was selected. Finally, the established methodology was successfully applied to spiked minipig serum with unlabelled PS-Liposomes, and the preservation of structural integrity after isolation was demonstrated by nanoparticle tracking analysis (NTA) and scanning electron microscopy (SEM).
PMID:41838109 | DOI:10.1007/s00216-026-06436-y
Source: https://pubmed.ncbi.nlm.nih.gov/4183810 ... t6+133c1fe
Si vous appréciez notre travail, merci de nous soutenir un petit don en cliquant ICI
Pour obtenir la traduction en français,
cliquez sur le bouton situé dans la barre des menus en haut de cette page

Pour les donateurs, si cet article vous intéresse, nous pouvons faire l’acquisition d'un tiré-à-part.
Merci d'en faire la demande sur association.amis-modo@myasthenie.com
Bonne lecture...
Pour obtenir la traduction en français,
cliquez sur le bouton situé dans la barre des menus en haut de cette page

Pour les donateurs, si cet article vous intéresse, nous pouvons faire l’acquisition d'un tiré-à-part.
Merci d'en faire la demande sur association.amis-modo@myasthenie.com
Bonne lecture...





